Funded Tech Companies
Dermavant Sciences
Headquartered in Long Beach, Dermavant Sciences is venture-backed, with investment from Marathon Asset Management, NovaQuest and private investors.
Company Overview
Company Name
Dermavant Sciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3780 Kilroy Airport Way 250
Long Beach, CA 90806
USA
Long Beach, CA 90806
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant's focus is to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/8/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Zavodnick
Chief Financial Officer
Michael Swartzburg
Chief Medical Officer
Philip Brown
Chief Scientific Officer
David Rubenstein
Vice President
Kristopher Garcia
Vice President
Kenneth Peist
Vice President
Steve Piscitelli
Vice President
Paul Seaback
Vice President
Anna Tallman
Vice President
Diana Villalobos
VP - Bus. Development
Chris Chapman
VP - Bus. Development
Peter Nicholson
VP - Finance
Mark Luz
VP - General Counsel
Christopher Van Tuyl
VP - Regulatory Affairs
Elaine Clark
Company Investors
- Marathon Asset Management (Steve DeNelsky)
- NovaQuest (Brian Axe)
Browse more funded tech companies:
DermAvance Pharmaceuticals | DermBiont
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs